Asceneuron SA @asceneuron_sa
Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders asceneuron.com Switzerland / USA Joined July 2021-
Tweets25
-
Followers71
-
Following352
-
Likes18
Meet the esteemed members of the first #PanelDiscussion of the #20thAnglonordic. Register Now: lnkd.in/ds-qUya Chaired by #LisaUrquhart, the panel will cover #Neurodegeneration with members from @MISSIONTherapeu, @asceneuron_sa, @alchemabtx and #VesperBio. #LifeSciences
@Aseceneuron_sa is pleased to appoint industry veteran Abbas Hussain as its new Chair to its Board at a pivotal time of growth & development. Learn more about Abbas’ experience and successes👉 asceneuron.com/news/abbas-hus… #parkinsons #alzheimers #tauopathies #companygrowth
#Asceneuron_sa is delighted to announce the appointment of Barbara Angehrn Pavik as the new Chief Executive Officer (CEO) 👉businesswire.com/news/home/2023…
Looking forward to connect with pharmaceutical executives to explore partnering and strategic opportunities in #Alzheimer disease at #BIO2023! 👉asceneuron.com/news/asceneuro…
This licensing agreement with Ferrer is important news for patients suffering from PSP and their families. Asceneuron, as a neurodegeneration-focused company, will continue expanding the application of OGA mechanism in other diseases in addition to... businesswire.com/news/home/2023…
#AsceneuronSA is delighted to announce the acquisition of ASN90 worldwide rights by #ferrer, to treat Progressive Supranuclear Palsy (PSP). asceneuron.com/news/ferrer-ac… #curepsp #ProgressiveSupranuclearPalsy #NeurodegenerativeDiseases #rarediseaseday2023 #rarediseaseday
Looking forward to meeting you at the Annual Biotech in Europe Forum today in Basel! #Asceneuron_SA CEO #DirkBeher will take part in the “CNS: Focus on Neurodegenerative Diseases” panel discussion scheduled at 12:05 PM, Room Ballroom. #Sachs_BEF #Sachs_SALSW
Join us at the #ASBMB O-GlcNAc conference on July 7–10, 2022 at the University of Georgia, Athens, Ga, USA! Our team will present ASN51, which has best-in-class potential to treat #Alzheimer’s Disease & other related neurodegenerative diseases. Program:asbmb.org/meetings-event…
La société lausannoise @asceneuron_sa , spin-off du groupe Merck Serono, a levé des dizaines de millions de francs pour s’attaquer à aux maladies de l’alzheimer et de Parkinson. Deux molécules prometteuses sont dans le pipeline. bilan.ch/story/asceneur…
Les molécules développées par @asceneuron_sa sont dirigées contre une enzyme (O-GlcNAcase ou OGA) qui élimine des sucres à la surface des protéines tau — sucre qui favorise leur agrégation heidi.news/innovation-sol…
#Asceneuron_SA has been awarded a second grant from The Michael J. Fox Foundation for Parkinson's Research (#MJFF) to accelerate the study of its clinical stage O-GlcNAcase inhibitor ASN51 as a potential new treatment for #Parkinsons disease. More: asceneuron.com/news/asceneuro…
While more than 7 million people live with Parkinson's disease, currently available treatments are symptomatic. @asceneuron_sa develops small molecules having the potential to deliver disease-modifying drugs to treat Parkinson’s disease. #ParkinsonsAwarenessWeek #FutureOfPD.
We are pleased to announce that @ACSPublications has published @asceneuron_sa’s pioneering #preclinical efficacy data on our novel #clinical molecule #ASN90 in both #Alzheimers and #Parkinsons disease models. More: bit.ly/3wUqZ7f #research #neurodegenerativediseases
@TheADDF @a_hfillit @cjbarnu @INmuneBio @radnucmp @ADmitTherapeut1 @BurkeNeuroSci @imperialcollege @AgeneBio @CodiPhd @Optinadx @diamir_bio @PhDForum @OpenAcademics 22nd International Conference on Alzheimer's Drug Discovery 1⃣ Clinical Trials & Novel Approaches for #Dementia 2⃣ Start-up Forum 3⃣Advances in Fluid Biomarkers 4⃣ Drug Development Approaches for Frontotemporal Dementia Register➡️meetings.alzdiscovery.org/alz-registrati… #AlzDiscovery #Alzheimers
CEO Dirk Beher will be presenting "OGA inhibitors as multimodal drugs for intracellular proteinopathies", at the 22nd International Conference on Alzheimer’s Drug Discovery today at 10:45am ET. Programme information: bit.ly/3uqdfhh #ADDF2021 #alzheimers @TheADDF
@asceneuron_sa to present data on its O-GlcNAcase inhibitor pipeline at the below conferences @TheADDF 04/10/21 - 16:45 CET @TheNewANA1 18/10/21 - 23:30 CET #EUROTAU 26/10/21 - 14:55 CET #alzheimers #neurodegenerativediseases #OGA # #ADDF2021 #ANA2021 #EUROTAU2021
us_Everly_ @UEverly50468
1 Followers 497 Following
Torrent @13Lily133814
2 Followers 485 Following
Fawn Swanson @fa_swans
61 Followers 5K Following
Valentina Bae @ValentinaB78077
35 Followers 5K Following
FlickFi_estaFaye @flickfi24481
8 Followers 1K Following
prrra00gz @prrra00gz68649
13 Followers 3K Following
VltWhsp_34 @vltwhsp98487
10 Followers 1K Following The best ideas are useless if they are not executed.
Savannah Elkin @SavannElk
68 Followers 5K Following
sweetoverripe @sweetoverr768
4 Followers 1K Following
SassySparrow_ @sassy_spar12410
1 Followers 162 Following
Isabella-rose Garro @rose_garro61361
61 Followers 5K Following
Harper @Harper919181026
7 Followers 165 Following
us_Autumn_ @UsAutumn70274
0 Followers 116 Following
us_Talia_ @TaliaUs10428
3 Followers 1K Following
UK DRI Biomarker Fact.. @UkdriL
997 Followers 594 Following We work on fluid biomarkers of dementia and other types of neurodegeneration and are part of the @UCLIoN and @UKDRI at UCL.
Daisy-mae Broll @BrollMae23204
67 Followers 5K Following
Thesan @thesan45314
29 Followers 2K Following
Kasha Lemarr @lemar_kas
29 Followers 5K Following
Rosalyn Mallahan @RosalMallah
36 Followers 4K Following
PrimaDavy @1qphUpPWc2DxbAx
13 Followers 242 Following
Sofinnova Partners @SofinnovaVC
3K Followers 753 Following Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.
Alessandro Palmieri @Juniorjack482
17 Followers 48 Following
Archos Search @ArchosSearch
91 Followers 405 Following Archos Search is a European Boutique focus in the LifeScience recruitment. We are partnering with innovative Biotech and SME Life science organisations. 🧬⚕️
Sara Picó, PhD @sarapico7
720 Followers 966 Following Venture Capital analyst intern at Debiopharm. Interested in digital health. 🚀👩💻🩺🩻💊she/her
MoeN @MoeN76499003
7 Followers 173 Following
Abdelrahman AlOkda @abdelalokda
30 Followers 101 Following Neuroscience PhD candidate in Van Raamsdonk's Lab at RI-MUHC 🇨🇦 C. elegans enthusiast - Aging and neurodegeneration
gautamethiraj @Gautam08105240
53 Followers 94 Following
Richard Margolin @inthethroes
193 Followers 2K Following
Jyotsna Misra @JyotsnaMisra5
26 Followers 535 Following Working as a final year graduate student at University of Wisconsin in Biochem field. Open to postdoc positions.
Celling Alpha @CellingAlpha
187 Followers 3K Following Tweets about biomedical sciences and finance. Ph.D., Not financial advice. Do your own research.
IXICO @IXICOnews
571 Followers 296 Following Neuroimaging provider, transforming data into clinically meaningful insights. The partner of choice for imaging biomarker solutions in CNS clinical trials.
Leticia Toledo-Sherma.. @leticiatosherm
439 Followers 1K Following Senior VP of Drug Discovery, MycRx Pharma, Oncology, Drug Discovery, Oncology, Neurodegenerative Diseases, Medicinal Chemistry, STEM
Sebastian Baez Lugo @sbaezlugo
94 Followers 206 Following Ph.D. Socio-Affective Neuroscience | UX Researcher
BioInnovation Institu.. @BioCPH
1K Followers 2K Following BII's Twitter account seeks to highlight the achievements of our community as well as to promote the agenda of life science innovation in the Nordics
PharmaVentures, The D.. @PharmaVentures
10K Followers 1K Following PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances.
ADmit Therapeutics @ADmitTherapeut1
403 Followers 832 Following Identification of early AD patients will contribute to identify effectives AD drugs
Proteinopathy @MAPTAU
129 Followers 172 Following Tracking scientific & business advances related to #tauopathies #mapt #taubiology #proteinopathies and entrepreneurs in neuroscience #teamtau
Cindy Blatchford @missycatcindy
0 Followers 73 Following
Xlife Sciences AG @xlifesciences
1K Followers 772 Following We invest in early stage #medtech & #lifesciences projects that help solve global health issues 🇨🇭 SIX: $XLS
J. Michael Ryan, MD @JMichael_Ryan
488 Followers 3K Following Neuroscience Drug Developer, Geriatric Psychiatrist & Entrepreneur
Paul Edwards @Bioedwards56
348 Followers 730 Following Over 40 years in the life science sector, cricket fan and passionate European. Opinions are my own. #lifesciences
Tran @tranbryannguyen
289 Followers 338 Following Biotech for life. CFO @ProthenaCorp fighting diseases caused by protein dysregulation. Steelers Warriors Giants UCLA and Poker fan My Opinions are my own
UK DRI Biomarker Fact.. @UkdriL
997 Followers 594 Following We work on fluid biomarkers of dementia and other types of neurodegeneration and are part of the @UCLIoN and @UKDRI at UCL.
OBN_UK @OBN_UK
5K Followers 3K Following OBN is the Membership organisation supporting and bringing together the UK’s #lifesciences R&D companies, their #corporate #partners and #investors.
John Carroll @JohnCendpts
70K Followers 94 Following Working journalist for 46 years, created FierceBiotech, founded Endpoints News now majority-@FT owned. 201,000 subscribers. These are personal opinions.
Sachs Associates @SachsAssociates
351 Followers 129 Following Sachs Associates is a long established international conference company focused on BioPharma, MedTech & Digital Health events for Investment & Partnering.
Darius Rafieyan @dariusrafieyan
2K Followers 2K Following Senior Reporter, VC & Startups @BusinessInsider / 2020-2021 Knight-Bagehot Fellow / MBA from @Columbia_Biz / cell & Signal: 714-651-1367 / [email protected]
FierceBiotech @FierceBiotech
101K Followers 649 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Interpharma @interpharma_ch
3K Followers 355 Following Interpharma ist der Verband der forschenden pharmazeutischen Firmen der Schweiz. News zu Lebensqualität, Forschung und Volkswirtschaft.
ScienceofParkinsons @ScienceofPD
10K Followers 267 Following Personal account of the Director of Research at @CureParkinsonsT - All views my own - Kiwi - Kia kaha - 侘寂
ACS Publications @ACSPublications
62K Followers 1K Following ACS Publications is proud to publish the most trusted, most cited, and most read collection of peer-reviewed journals in the chemical and related sciences.
Xlife Sciences AG @xlifesciences
1K Followers 772 Following We invest in early stage #medtech & #lifesciences projects that help solve global health issues 🇨🇭 SIX: $XLS
Ben Hirschler @reutersBenHir
19K Followers 2K Following Former #Reuters global pharmaceuticals correspondent in London. Now freelance writer and consultant.
OpenAcademics @OpenAcademics
132K Followers 9K Following Twitter community to support academics across all disciplines. @OpenAcademics for RT. #DiversityAndInclusion #MentalHealth #AcademicTwitter
PhD Forum @PhDForum
118K Followers 48K Following Welcome, you each make this a supportive & knowledgeable community. Use our FREE online study room 24/7 details via our website or bluesky, telegram & Mastodon.
DiamiR @diamir_bio
32 Followers 23 Following We are developing blood-based tests for early detection and monitoring of brain health conditions to enable earlier intervention and better planning of care.
Optina Diagnostics @Optinadx
47 Followers 2 Following
Codi A Gharagouzloo, .. @CodiPhd
27 Followers 193 Following Scientist, Entrepreneur, Christian, Husband and Father of Two
AgeneBio @AgeneBio
131 Followers 38 Following AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.
Imperial College Lond.. @imperialcollege
181K Followers 3K Following A global top-ten university, where scientific imagination leads to world-changing impact. Science | Engineering | Medicine | Business. #OurImperial 💙
Burke Neurological In.. @BurkeNeuroSci
480 Followers 140 Following We bring hope to those living with neurological disabilities. We translate groundbreaking research into treatments that help people see, talk, and walk again.
ADmit Therapeutics @ADmitTherapeut1
403 Followers 832 Following Identification of early AD patients will contribute to identify effectives AD drugs
Martin Pomper @radnucmp
268 Followers 8 Following Physician-scientist in molecular imaging and therapy at Johns Hopkins. Development of precision imaging agents.
Krzysztof Potempa @BRAINCURES
3K Followers 5K Following Founder & CEO @BRAINCURESLtd and dreamster dedicated to prevention and treatment of mental health disorders that affect at least 1 in 6 people worldwide
INmune Bio Inc. @INmuneBio
5K Followers 5K Following INmune Bio (Nasdaq: INMB) is developing therapies that harness patient’s immune system to treat disease. Our focus is on #cancer, #Alzheimer’s disease.
World Health Organiza.. @WHO
12.3M Followers 2K Following We are the #UnitedNations’ health agency - #HealthForAll. ▶️ Always check our latest tweets on #COVID19 for updated advice/information.
Neurology: Clinical P.. @NeurologyCP
28K Followers 361 Following Neurology® Clinical Practice is an official publication of the American Academy of Neurology.
Abhimanyu Mahajan @AMahajanMD
5K Followers 2K Following Movement disorders neurologist and Assistant Professor @UCincyMedicine| Science. Clinical care. Occasionally, Policy| Views are my own, not medical advice. 🧠
Medscape Neurology @MedscapeNeuro
45K Followers 370 Following Medscape Neurology provides you with breaking medical news; reference on drugs,diseases,and procedures; and free CME.
Stacey Clardy MD PhD @StaceyLClardy
7K Followers 6K Following MD PhD Autoimmune Neurologist. Assoc. Prof @UofUNeurology. Section Editor, Neurology Podcast @GreenJournal & Neurology Minute @AANmember. Opinons=mine.
Neurology Journal @GreenJournal
92K Followers 1K Following Neurology is the most widely read and highly cited peer-reviewed neurology journal. It is the medical journal for the American Academy of Neurology.
American Neurological.. @TheNewANA1
11K Followers 2K Following ANA is a professional society of academic neurologists and neuroscientists. Interested in becoming a member? Visit https://t.co/PT9HNOkmsG to learn more!
Groupe ADP @GroupeADP
12K Followers 662 Following Accueillir les passagers, exploiter & imaginer des aéroports de manière responsable dans 50 pays, sur 120 aéroports 🛫 Support passager sur @ParisAeroport
Venture @Venture_conf
311 Followers 660 Following A meeting place for the people with the inside track on investment. The largest venture capital conference globally, held alongside @WebSummit | Nov 5 @deckelly
Julien Creuzé @jcreuze
1K Followers 935 Following VC @ BlackFin #Fintech #Insurtech #startup #VC #Europe
EricMartineau-Fortin @emf
1K Followers 759 Following Founder and Managing Partner of White Star Capital
inato @inatohealth
147 Followers 24 Following Inato is unlocking access to trials in the community by creating a global clinical trial platform that brings research to patients where they live.
Venture Capital Journ.. @VCJournal
7K Followers 794 Following Twitter stream for readers of Venture Capital Journal.
Alastair Goldfisher @agoldfisher
10K Followers 7K Following Longtime business reporter/editor, covering #venture #VC #startups #tech. Now platform services provider + content writer. Open to network. DM me to connect
Callum Burroughs @CallumBurroughs
4K Followers 8K Following Your friendly neighbourhood startups correspondent. I cover startups and VC for @businessinsider in London. Tips: [email protected], DMs open. He/him. BLM.
Katie Roof @Katie_Roof
53K Followers 8K Following Roof, like the Fiddler. VC/tech deals for Bloomberg @business @bloombergdeals. M&A, IPOs & late stage VC. LA again via SF and NYC. Views my own.
Jaclyn Hartnett @JkHartnett
233 Followers 400 Following Head of Comms @CathayInnov ; Creative Writer (also non-creative writer); terrible @ Tweeter 🐢
Vincent Sebag @vincentsebag
134 Followers 403 Following VC investor @ Cathay Innovation Crypto, deep tech and healthcare enthusiast
Lucy Handley @lucyhandley
5K Followers 8K Following Award-winning journalist and ghostwriter | Writing about art for @CNBCi | https://t.co/NBcotltlu1 | [email protected] | All about me: https://t.co/3ewMnYd33V
Alex Konrad @alexrkonrad
80K Followers 3K Following Senior editor @Forbes covering venture capital and tech. Edit the Midas List, Cloud 100 and 30 Under 30 VC. Plus one to @N_Sportelli. email: [email protected]
Amy Lewin @amyrlewin
19K Followers 1K Following Editor @siftedeu, covering startups and tech, backed by the FT | [email protected] | For our latest, greatest stories, sign up to our newsletters 👇
Sifted @Siftedeu
36K Followers 4K Following In-depth reporting on startup Europe, for startup Europe. 🇪🇺 Subscribe to Sifted Pro for vital market intelligence: https://t.co/M3g11175y3
Biz Carson @bizcarson
26K Followers 2K Following Bloomberg reporter covering @wealth and Silicon Valley. Ex-Protocol, Forbes, Business Insider, Gigaom, & Wired. Atlanta native, IU Hoosier.
We value our partnership with @RCFNeuro and the @alzassociation @DrMariaALZ We’re thrilled to have more than 500 multidisciplinary attendees today for #tau2024 in DC
Meet the esteemed members of the first #PanelDiscussion of the #20thAnglonordic. Register Now: lnkd.in/ds-qUya Chaired by #LisaUrquhart, the panel will cover #Neurodegeneration with members from @MISSIONTherapeu, @asceneuron_sa, @alchemabtx and #VesperBio. #LifeSciences
🤩 Auditorium I is packed for the opening ceremony of #ADPD2024! @clemere99
Welcome to #ADPD2024! The conference has officially kicked off, and we're thrilled to be here in #Lisbon with our global community of experts in #neurodegenerative diseases. 🧠 Stay tuned for more updates and insights as we delve into the latest advancements in the field. 🌟
Less than 1 week to confirm your attendance⏱Don’t miss your chance to attend this in-person event on June 4 with @JLABS and the @BARDA in association with #BIO2023 in Boston, MA! bit.ly/41Z9HTm
The #ADDF is proud to be a sponsor at this year's #BIO2023, which will take place next week June 5-8. We are excited to attend and meet with companies at the forefront of innovation to discuss the scientific ideas that will help us defeat #Alzheimers: bit.ly/38YGCRG
Join us & others for our West Coast CNS Therapeutics Xchange in San Francisco Sept 29. View agenda & register at bit.ly/3yGyUWa. Open to Senior Scientists in the pharma/biotech industry. #lifesciences #CNS #therapies #pharmacology #Biotechnology #drugdelivery #clinical
Les molécules développées par @asceneuron_sa sont dirigées contre une enzyme (O-GlcNAcase ou OGA) qui élimine des sucres à la surface des protéines tau — sucre qui favorise leur agrégation heidi.news/innovation-sol…
La biotech lausannoise @asceneuron_sa vient de publier des recherches prometteuses sur une molécule efficace contre plusieurs maladies neurologiques et d’obtenir un financement de la Fondation de l’acteur @realmikefox heidi.news/innovation-sol…
@asceneuron_sa has today announced that it has been awarded a second grant from The Michael J. Fox Foundation for Parkinson's research for accelerated research into novel #Parkinson's disease therapies. Read more: bit.ly/3w1PaPc #neurodegenerativediseases #OGA #ASN51
We'd like to also extend a very special thank you to our sponsors: Alectos Therapeutics, @asceneuron_sa, @SFGlycobiology & @thermofisher! #ASBMBOGlcNAc
Friendly reminder: The deadline to submit your #ASBMBOGlcNAc abstract is just days away! The conference will address the multitude of roles that the O-GlcNAc protein modification has in regulating nuclear & cytosolic proteins. Submit your abstract by 4/26. asbmb.org/meetings-event…
In ASBMB Today, @gwhart13 & @DocGatorDawg1 discussed their upcoming #ASBMBOGlcNAc meeting: asbmb.org/asbmb-today/sc…. Planning to join us this summer? Submit your abstract by 4/26! Special thanks to our sponsors: @asceneuron_sa, @ga_res_alliance, @thermofisher & @SFGlycobiology.
Come together for the more than 10 million people living with Parkinson's disease around the world 🌍💙🔬🔊🌏 Through advanced research and increased awareness, we can alter the #FutureOfPD. Here's how you can get involved this #WorldParkinsonsDay: Parkinson.org/Awareness
@TheADDF @a_hfillit @alzassociation @AgeneBio @asceneuron_sa reported on its novel compound, which inhibits the enzyme O-GlcNAcase. @TheADDF announced a $2.2 million investment earlier this year supporting the first testing of the drug in healthy volunteers @Oligomerix compound disrupts tau’s ability x.com/a_hfillit/stat…
#AAIC21 featured many novel compounds in development, demonstrating the #Alzheimers pipeline's diversity. @asceneuron_sa's compound keeps tau from becoming toxic, while @Oligomerix's disrupts tau’s ability to attach to itself & create tangles: bit.ly/3seCbaA #FillitFive
#AAIC21 featured many novel compounds in development, demonstrating the #Alzheimers pipeline's diversity. @asceneuron_sa's compound keeps tau from becoming toxic, while @Oligomerix's disrupts tau’s ability to attach to itself & create tangles: bit.ly/3seCbaA #FillitFive
#AAIC21 featured the latest in #Alzheimers research, touching on progress in phase 2 trials, developments in #biomarkers, #prevention, #brainhealth, and more. Our CSO @a_hfillit broke down the news coming out of this conference in our latest blog: bit.ly/3seCbaA
Asceneuron SA’s unique approach to treat Alzheimer’s disease featured by our CEO Dirk Beher in series of interviews with industry leaders on the future of #Alzheimer's disease drug development. Read the article published by @INVIVOnow : invivo.pharmaintelligence.informa.com/IV124857/Preci…
Trends for United States
You might like
